Overall n First Study (n=58) Second Study (n=55)
Males     26 26
Females 32 29
p-value (d) p=0.851 (b)
Mean age (years) 43.3        49.6
Number of respondents 58 54
p-value (d) p=0.0180 (c)
Cold Sores per year
Mean 4.2 4.9
Median 4.0 3.0
Number of respondents 58 54
p-value (a) p=0.488 (b)  
Untreated Cold Sore Duration – Loss of hard scab     
Mean 11.1 days 11.5 days
Median  10.0 days 11.0 days
Number of respondents 58 54
p-value (a) p=0.588 (b)
Viroxyn Time to healing
Mean 4.0 4.0
Median  3.0 4.0
Number of respondents 58 55
p-value (a) p=0.966 (b)
Untreated Time to loss of discomfort
Mean     6.2 days 6.2 days
Median  5.0 days 6.0 days
Number of respondents 57 51
p-value (a)            p=0.991 (b)
Viroxyn Time to loss of discomfort
Mean     0.53 days 0.73 days
Median 0.007 days 0.042 days
Number of respondents 58 54
p-value  p=0.412 (b)
P-value Viroxyn v. Control (a) <0.001 (c)
a. Two Tail Independent t-test
b. Confirms the null hypothesis of no difference between studies
c. Statistically significant difference between studies
d. Fishers exact test
Table 3: Results of Analysis - Abreva Naïve Group.